UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

European journal of cancer (1990), 2019-07, Vol.116, p.116-136

2019

Volltextzugriff (PDF)

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

Annals of oncology, 2011-11, Vol.22 (11), p.2476-2481

2011

Volltextzugriff (PDF)

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

Annals of oncology, 2005-07, Vol.16 (7), p.1152-1159

2005

Volltextzugriff (PDF)

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)

Annals of oncology, 2007-05, Vol.18 (5), p.917-924

2007

Volltextzugriff (PDF)

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia

European journal of cancer (1990), 2014-08, Vol.50 (12), p.2082-2089

2014

Volltextzugriff (PDF)

Insulin-Like Growth Factor (IGF) family and prostate cancer

Critical reviews in oncology/hematology, 2006-05, Vol.58 (2), p.124-145

2006

Volltextzugriff (PDF)

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors

Annals of oncology, 2013-02, Vol.24 (2), p.322-328

2013

Volltextzugriff (PDF)

Potential drug interactions in elderly cancer patients

Critical reviews in oncology/hematology, 2011-06, Vol.78 (3), p.220-226

2011

Volltextzugriff (PDF)

Occupational exposures in rare cancers: A critical review of the literature

Critical reviews in oncology/hematology, 2014-05, Vol.90 (2), p.99-134

2014

Volltextzugriff (PDF)

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

British journal of cancer, 2005-10, Vol.93 (8), p.909-914

2005

Volltextzugriff (PDF)

Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors

Annals of oncology, 2002-07, Vol.13 (7), p.1017-1028

2002

Volltextzugriff (PDF)

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

Annals of oncology, 2005-03, Vol.16 (3), p.411-418

2005

Volltextzugriff (PDF)

Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature

Cancer treatment reviews, 2021-11, Vol.100, p.102289-102289, Article 102289

2021

Volltextzugriff (PDF)

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

European journal of cancer (1990), 2000-07, Vol.36 (11), p.1389-1394

2000

Volltextzugriff (PDF)

Chemotherapy in advanced androgen-independent prostate cancer 1990–1999: A decade of progress?

Annals of oncology, 2000-12, Vol.11 (12), p.1523-1530

2000

Volltextzugriff (PDF)

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2638-2645

1996

Volltextzugriff (PDF)

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

JNCI : Journal of the National Cancer Institute, 2000-01, Vol.92 (1), p.54-61

2000

Volltextzugriff (PDF)

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

Annals of oncology, 2000-02, Vol.11 (2), p.151-156

2000

Volltextzugriff (PDF)

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3386-3391

1998

Volltextzugriff (PDF)

Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry

Rapid communications in mass spectrometry, 2005-01, Vol.19 (17), p.2419-2426

2005

Volltextzugriff (PDF)

Pattern of Relapse after First Line Treatment of Advanced Stage Germ-Cell Tumors

European urology, 2005-12, Vol.48 (6), p.957-964

2005

Volltextzugriff (PDF)

Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force

Critical reviews in oncology/hematology, 2007-04, Vol.62 (1), p.62-73

2007

Volltextzugriff (PDF)

Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres

Annals of oncology, 2001-09, Vol.12 (9), p.1313-1319

2001

Volltextzugriff (PDF)

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

European journal of cancer (1990), 2001-11, Vol.37 (17), p.2194-2198

2001

Volltextzugriff (PDF)

Doxorubicin and Ifosfamide in Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Phase II Study of the Genitourinary Group of the French Federation of Cancer Centers

The Journal of urology, 2002-09, Vol.168 (3), p.959-961

2002

Volltextzugriff (PDF)

1 – 25 von 570

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(478)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(431)
Male
(310)
Science & Technology
(265)
Life Sciences & Biomedicine
(255)
Adult
(248)
Middle Aged
(214)
Female
(190)
Oncology
(177)
Biological And Medical Sciences
(169)
Medical Sciences
(167)
Aged
(138)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(128)
Adolescent
(105)
Chemotherapy
(94)
Pharmacology. Drug Treatments
(92)
Prognosis
(91)
Antineoplastic Agents
(78)
Combined Modality Therapy
(75)
Cisplatin - Administration & Dosage
(67)
Follow-Up Studies
(55)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bulletin Du Cancer
(56)
European Journal Of Cancer
(41)
Journal Of Clinical Oncology
(26)
Annals Of Oncology
(25)
Cancer
(20)
La Presse Médicale
(20)
The Journal Of Urology
(19)
La Nouvelle Presse Medicale
(17)
Journal D'urologie
(16)
Critical Reviews In Oncology/hematology
(11)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia

Insulin-Like Growth Factor (IGF) family and prostate cancer

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors

Potential drug interactions in elderly cancer patients

Occupational exposures in rare cancers: A critical review of the literature

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

Chemotherapy in advanced androgen-independent prostate cancer 1990–1999: A decade of progress?

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry

Pattern of Relapse after First Line Treatment of Advanced Stage Germ-Cell Tumors

Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force

Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

Doxorubicin and Ifosfamide in Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Phase II Study of the Genitourinary Group of the French Federation of Cancer Centers

Suchergebnisse filtern